Improve walking through transcranial stimulation
- Trial ID
- NCT07182058
- Official Title
- Virtual Remote Assessment of Transcranial Electrical Stimulation for Parkinson's Disease Motor Symptoms
- Goal
- Improve walking through transcranial stimulation
- Phase
- PHASE1, PHASE2
- Status
- RECRUITING
- Sponsor
- U: The Mind Company
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- PARKINSON DISEASE (Disorder)
- Interventions
- Transcranial Electrical Stimulation Device
Plain-Language Summary
It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.
Locations
- U LLC Headquarters, Cleveland, Ohio, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Transcranial Electrical Stimulation Device. It aims to ease motor symptoms like tremor, slowness, and stiffness by testing whether remotely delivered transcranial electrical stimulation can safely improve movement in people with Parkinson's. The device sends gentle, low-level electrical currents through the scalp to tweak the excitability of motor brain circuits, sessions are done at home with telehealth supervision, and it is studied as an add-on rather than a replacement for levodopa or other Parkinson's medications so participants need a stable regimen. Looking for adults 18 to 80 with Parkinson's at Hoehn and Yahr stages 1 to 4 who have stable meds and reliable internet; people with metal head or neck implants, a history of seizures, recent stroke, pregnancy, severe cognitive impairment, serious skin problems at electrode sites, or current participation in other trials are excluded.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This Phase 1/Phase 2 trial is estimated to last approximately 2 months.